UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): May 1, 2012
PolyMedix, Inc.
(Exact Name of Registrant as Specified in Charter)
| | | | | |
| Delaware | | 000-51895 | | 27-0125925 |
(State or Other Jurisdiction of Incorporation or Organization) | | (Commission File Number) | | (I.R.S. Employer Identification Number) |
| | | |
170 N. Radnor-Chester Road; Suite 300 Radnor, Pennsylvania | | 19087 |
| (Address of Principal Executive Offices) | | (Zip Code) |
(484) 598-2400
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | ¨ | Written communications pursuant to Rule 425 under the Securities Act |
| | ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
| | ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
| | ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
| Item 5.07. | Submission of Matters to a Vote of Security Holders. |
On May 1, 2012, PolyMedix, Inc. (the “Company”) held its 2012 Annual Meeting of Shareholders. At the meeting, the shareholders voted to elect of seven directors and to approve three other proposals. The results of the election and the voting on the other proposals were as follows:
Proposal 1: To elect seven directors to the board of directors of PolyMedix, Inc., each to serve until the 2013 Annual Meeting of Stockholders, and until his successor is elected and qualified:
| | | |
| Nicholas Landekic | 36,896,015 | 12,214,243 | 37,270,746 |
| Brian Anderson | 38,654,105 | 10,456,153 | 37,270,746 |
| Frank P. Slattery, Jr. | 39,570,634 | 9,539,624 | 37,270,746 |
| Michael Lewis, Ph.D. | 39,033,286 | 10,076,972 | 37,270,746 |
| Stefan Loren, Ph.D. | 39,428,864 | 9,681,394 | 37,270,746 |
| Shaun O’Malley | 39,272,214 | 9,838,044 | 37,270,746 |
| Douglas Swirsky | 38,991,944 | 10,118,314 | 37,270,746 |
| | | | |
Proposal 2: To approve, on an advisory basis, the compensation of the Company’s named executive officers:
| | | |
| 33,802,758 | 14,088,051 | 1,219,449 | 37,270,746 |
| | | | |
Proposal 3: To approve an amendment to the Company’s certificate of incorporation to combine outstanding shares of the Company’s common stock into a lesser number of outstanding shares, a “reverse stock split,” by a ratio of not less than two-for-one and not more than six-for-one at any time prior to the 2013 Annual Meeting of Stockholders, with the exact ratio to be set within this range by the Company’s board of directors in its sole discretion:
| | | |
| 55,417,969 | 29,521,811 | 1,233,870 | 207,354 |
| | | | |
Proposal 4: To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2012:
| | | |
| 82,873,005 | 2,156,700 | 1,351,297 | 0 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | POLYMEDIX, INC. |
| | | |
| Date: May 4, 2012 | | By: | | /s/ Edward F. Smith |
| | | | | |
| | | | | Edward F. Smith Vice President, Finance and Chief Financial Officer |
